| Rebecca A Levy, MD | |
|
390 E Longview St, Fayetteville, AR 72703-4618 | |
| (479) 601-1175 | |
| Not Available |
| Full Name | Rebecca A Levy |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 17 Years |
| Location | 390 E Longview St, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396940607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | E-7307 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
| Washington Regional Medical Center | Fayetteville, AR | Hospital |
| Northwest Medical Center-springdale | Springdale, AR | Hospital |
| Siloam Springs Regional Hospital | Siloam springs, AR | Hospital |
| Mercy Hospital Berryville | Berryville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Arkansas Pathology Associates Pa | 8729013495 | 11 |
| Cherokee Nation | 5799698742 | 329 |
News Archive
Significant gains made through multi-hospital cooperative effort led by U-M Cardiovascular Center and funded by Blue Cross Blue Shield of Michigan.
Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.
An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.
Devax, Inc. announced today the company received CE Mark for its AXXESS™ Biolimus A9® Eluting Coronary Bifurcation Stent System, allowing the company to initiate sales in the European Union and other countries that recognize the CE Mark.
› Verified 9 days ago
| Entity Name | Northwest Arkansas Pathology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306819263 PECOS PAC ID: 8729013495 Enrollment ID: O20051011000115 |
News Archive
Significant gains made through multi-hospital cooperative effort led by U-M Cardiovascular Center and funded by Blue Cross Blue Shield of Michigan.
Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.
An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.
Devax, Inc. announced today the company received CE Mark for its AXXESS™ Biolimus A9® Eluting Coronary Bifurcation Stent System, allowing the company to initiate sales in the European Union and other countries that recognize the CE Mark.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca A Levy, MD 4301 W Markham St Slot 517, Dept Of Pathology, Little Rock, AR 72205-7199 Ph: (501) 686-7966 | Rebecca A Levy, MD 390 E Longview St, Fayetteville, AR 72703-4618 Ph: (479) 601-1175 |
News Archive
Significant gains made through multi-hospital cooperative effort led by U-M Cardiovascular Center and funded by Blue Cross Blue Shield of Michigan.
Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.
An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.
Devax, Inc. announced today the company received CE Mark for its AXXESS™ Biolimus A9® Eluting Coronary Bifurcation Stent System, allowing the company to initiate sales in the European Union and other countries that recognize the CE Mark.
› Verified 9 days ago
Dr. Paul R Hendrycy, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Bradley Dilday, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Jamie M Boone, D.O. Pathology Medicare: Medicare Enrolled Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Gregory Mckenzie, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 | |
Dr. Thomas J Simmons, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Saran Kraichoke, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Robert Morris Levy, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, P&lms (113), Fayetteville, AR 72703 Phone: 479-443-4301 |